MX9603741A - Composicion de liberacion mantenida. - Google Patents

Composicion de liberacion mantenida.

Info

Publication number
MX9603741A
MX9603741A MX9603741A MX9603741A MX9603741A MX 9603741 A MX9603741 A MX 9603741A MX 9603741 A MX9603741 A MX 9603741A MX 9603741 A MX9603741 A MX 9603741A MX 9603741 A MX9603741 A MX 9603741A
Authority
MX
Mexico
Prior art keywords
delivery composition
sustained delivery
quaternary ammonium
bioactive agent
ammonium surfactant
Prior art date
Application number
MX9603741A
Other languages
English (en)
Other versions
MXPA96003741A (es
Inventor
Taro Iwamoto
Akio Kimura
Takehiko Ohyama
Yasuyuki Takahashi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26671090&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9603741(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9603741A publication Critical patent/MX9603741A/es
Publication of MXPA96003741A publication Critical patent/MXPA96003741A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invencion, proporciona una composicion de liberacion mantenida que comprende una matriz PLGA, un agente bioactivo y un tensioactivo de amonio cuaternario, en el cual el perfil de liberacion del agente bioactivo de la matriz PLGA, se controla mediante la concentracion del tensioactivo de amonio cuaternario.
MXPA/A/1996/003741A 1995-08-30 1996-08-29 Composicion de liberacion mantenida MXPA96003741A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US296595P 1995-08-30 1995-08-30
US002965 1995-08-30
US08/560,081 US5759583A (en) 1995-08-30 1995-11-17 Sustained release poly (lactic/glycolic) matrices

Publications (2)

Publication Number Publication Date
MX9603741A true MX9603741A (es) 1997-05-31
MXPA96003741A MXPA96003741A (es) 1997-09-04

Family

ID=

Also Published As

Publication number Publication date
EP0761211B1 (en) 2001-05-30
DK0761211T3 (da) 2001-09-10
CN1152468A (zh) 1997-06-25
DE69613062T2 (de) 2002-03-21
PT761211E (pt) 2001-10-30
BR9603619A (pt) 1998-05-19
JP3977463B2 (ja) 2007-09-19
ES2158202T3 (es) 2001-09-01
CN1177614C (zh) 2004-12-01
DE69613062D1 (de) 2001-07-05
JPH09110726A (ja) 1997-04-28
BR9603619B1 (pt) 2009-05-05
CA2183620A1 (en) 1997-03-01
CA2183620C (en) 2010-01-19
US5759583A (en) 1998-06-02
GR3036436T3 (en) 2001-11-30
ATE201590T1 (de) 2001-06-15
TR199600695A2 (tr) 1997-03-21
EP0761211A1 (en) 1997-03-12

Similar Documents

Publication Publication Date Title
GR3036436T3 (en) Sustained release composition
TW286273B (es)
AU8865998A (en) Improved multiparticulate tablet with quick disintegration
HK1017995A1 (en) Compounds and compositions for delivering active agents.
ZA98792B (en) Bar compositions comprising adjuvant powders for delivering benefit agent and process for the manufacture of said bars.
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
NZ511773A (en) Compositions and methods for treating hair and skin using aqueous delivery systems
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
WO2003043586A3 (en) Compositions for sustained action product delivery
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
GB2288732B (en) Pharmaceutical compositions
NZ260989A (en) Xylanase derived from bacillus pumilus prl b12 or from b.licheniformis and mutants and variants thereof
AU1565300A (en) Anti-germinating method for tubers and bulbs using eugenol and/or isoeugenol
WO1999016416A3 (de) Beschichtete medizinische implantate, verfahren zu ihrer herstellung und ihre verwendung zur restenoseprophylaxe
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
MX9603607A (es) Matriz insecticida y su proceso de preparacion.
WO1999038532A3 (en) Methods for the prevention and treatment of fibrosis and sclerosis
WO1995016432A3 (en) Cosmetic cleansing composition with dual blooming perfume system
HUP0001681A3 (en) Hypochlorite bleaching composition, method for bleaching and delivery systems therefor
PL343376A1 (en) Controlled release tablet produced from linear water-insoluble polysaccharides
AU1230800A (en) Controlled delivery of antidepressants
AR004948A1 (es) Composicion de liberacion sostenida que contiene un copolimero de poli (acido lactico/glicolico), un agente terapeutico y un tensioactivo de amonio cuaternario
WO1996024378A3 (en) Delivery of exogenous compounds
GB9709815D0 (en) Therapeutic method
WO2001079411A8 (en) Water-softener in powdered form with an effervescent system